LEWIS RANDALL J 4
4 · Guardian Pharmacy Services, Inc. · Filed May 7, 2026
Research Summary
AI-generated summary of this filing
Guardian Pharmacy (GRDN) Director Randall J. Lewis Receives 4,028 RSUs
What Happened
- Randall J. Lewis, a director of Guardian Pharmacy Services, Inc. (GRDN), was granted 4,028 restricted stock units (RSUs) on May 5, 2026. The Form 4 reports the acquisition code "A" at a reported price of $0.00 because RSUs are awards payable in shares rather than priced purchases. No cash was exchanged in this grant.
Key Details
- Transaction date: 2026-05-05; Form 4 filed: 2026-05-07 (filed within the usual 2‑business‑day window).
- Amount: 4,028 RSUs; reported price: $0.00 (typical for RSU grants).
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnote: These are restricted stock units payable solely in Class A common stock of the issuer (per footnote F1).
- Transaction type: Award/grant (code A). No 10b5-1 plan, tax withholding, or sale noted in the excerpt.
Context
- RSUs are a form of equity compensation that convert to shares if and when vesting conditions are met; they do not require an exercise payment. Grants are common for board or employee compensation and do not necessarily indicate immediate buying or selling activity. This filing reports an award (acquisition of RSU rights), not an open‑market purchase or sale.
Insider Transaction Report
Form 4
LEWIS RANDALL J
Director
Transactions
- Award
Class A Common Stock
[F1]2026-05-05+4,028→ 15,071 total
Footnotes (1)
- [F1]Represents restricted stock units payable solely in shares of Class A common stock of the Issuer.
Signature
/s/ Douglas Towns, Attorney-in-Fact|2026-05-07